The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL
Crossref DOI link: https://doi.org/10.1186/s12933-017-0548-0
Published Online: 2017-05-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanefeld, Markolf
Traylor, Louise
Gao, Ling
Landgraf, Wolfgang
Funding for this research was provided by:
Sanofi
